Allarity Therapeutics annual return on equity
2021
2022
2024
2025
Allarity Therapeutics Return on Equity (ROE) Growth & History (ALLR)
Allarity Therapeutics's return on equity was −103.80% for fiscal 2025.
View full Allarity Therapeutics company overviewAllarity Therapeutics annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −103.80% | +437.37 pp |
| 2024 | 2024-12-31 | −541.17% | — |
| 2022 | 2022-12-31 | −178.04% | −52.90 pp |
| 2021 | 2021-12-31 | −125.13% | — |
Allarity Therapeutics quarterly return on equity
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −65.13% | −50.08 pp |
| Q1 2026 | 2026-03-31 | −32.84% | −14.91 pp |
| Q4 2025 | 2025-12-31 | −30.89% | +29.28 pp |
| Q3 2025 | 2025-09-30 | −23.21% | +47.46 pp |
| Q2 2025 | 2025-06-30 | −15.05% | +9.33 pp |
| Q1 2025 | 2025-03-31 | −17.93% | — |
| Q4 2024 | 2024-12-31 | −60.17% | — |
| Q3 2024 | 2024-09-30 | −70.67% | — |
| Q2 2024 | 2024-06-30 | −24.38% | — |
| Q4 2022 | 2022-12-31 | −425.49% | −355.15 pp |
| Q3 2022 | 2022-09-30 | −107.02% | −102.03 pp |
| Q2 2022 | 2022-06-30 | −44.96% | — |
| Q1 2022 | 2022-03-31 | −18.73% | — |
| Q4 2021 | 2021-12-31 | −70.34% | — |
| Q3 2021 | 2021-09-30 | −4.99% | — |
Allarity Therapeutics return on equity trends
Between the periods ended 2021-12-31 and 2025-12-31, Allarity Therapeutics's return on equity increased from −125.13% to −103.80%, a change of +21.33 percentage points. The latest reported quarter, Q2 2026, shows −65.13%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Allarity Therapeutics source filings ↗